Joint Venture / Consortium Stage

Complete a focused intervention that advances Joint Venture / Consortium Stage. The objective is to remove ambiguity around EU consortium role, partners, work packages, impact and budget, give the founder a decision-ready output, and make it clear whether the venture should progress, repeat the task with stronger evidence, escalate to expert support, or move into a linked stage.

Bertie or a programme manager assigns Joint Venture / Consortium Stage when the venture needs a decision-ready output for this group. Typical triggers include group-gate reviews, evidence gaps identified by the co-pilot or founder request.

target partner type; value proposition; product readiness; commercial model; current partner conversations; specific context for EU consortium role, partners, work packages, impact and budget.

1. 1Define Scope and Strategic Rationale for Consortiumexpand_more

   Establish why participating in or leading an EU consortium aligns with the venture's commercial growth and non-dilutive funding strategy. The founder identifies the specific strategic objectives, such as regulatory access, technology validation, or international market expansion, that this collaborative structure must unlock.

   Objective

   Clarifying the task purpose aligns the consortium strategy directly with the venture's overarching commercial goals. It prevents the team from pursuing complex grant-driven partnerships that distract from core product scaling priorities.

   What's expected

   The founder must produce a one-page strategic rationale outlining the primary motivations for joining an EU consortium. This document must explicitly state targeted strategic benefits, acceptable resource commitment levels, and non-negotiable commercial priorities.

   Consultant stress-test · 5 questions

   1. 1.What core commercial milestones will this EU consortium help the venture achieve faster than organic growth?
   2. 2.How do you ensure that pursuing Horizon Europe or similar funding does not divert critical engineering capacity away from your core product roadmap?
   3. 3.What specific market or regulatory barriers does entering a consortium resolve that direct market entry cannot?
   4. 4.Why is a formal joint venture or consortium the optimal structure compared to a standard commercial partnership or licensing agreement?
   5. 5.What clear criteria will you use to walk away if the consortium's objectives start to drift from your commercial strategy?

   Open action arrow_forward
2. 2Map EU Consortium Roles Work Packages and Budgetexpand_more
3. 3Audit Internal Capabilities and Target Partner Credentialsexpand_more
4. 4Construct Consortium Term Sheet and Decision Matrixexpand_more
5. 5Stress Test Consortium Architecture and Evidence Qualityexpand_more
6. 6Log Data Room Assets and Select Next Stepexpand_more

• A data-room asset titled Joint Venture / Consortium Stage
• A clear task output, updated venture DNA and recommended next action
• It should update the venture DNA with specific evidence or decisions about EU consortium role, partners, work packages, impact and budget, create a visible milestone in the founder journey, and generate one or more recommended next tasks

A mentor or evaluator can review the output at the group gate. Programme managers can require an advisor checkpoint before Bertie moves the venture forward.

Draft your output and let Bertie review it